发明名称 NAPHTHALIMIDOBENZAMIDE DERIVATIVES
摘要 <p>The present invention relates to a naphthalimidobenzamide derivative represented by the following formula (1): &lt;CHEM&gt; (wherein, R&lt;1&gt; represents a hydrogen atom, etc., Y represents a hydrogen atom or -CON(R&lt;4&gt;)-A&lt;2&gt;-X&lt;2&gt;, R&lt;2&gt; and R&lt;4&gt; are the same or different and each independently represents a hydrogen atom, etc., A&lt;1&gt; and A&lt;2&gt; are the same or different and each independently represents an alkylene group which may be interrupted at least once by -N(R&lt;3&gt;)- (R&lt;3&gt; representing a hydrogen atom, etc.) and X&lt;1&gt; and X&lt;2&gt; are the same or different and each independently represents a (hetero)aryl group which may have a substituent, etc.) or salt thereof; and a pharmaceutical comprising it as an effective ingredient. The compound is useful as an antitumor agent and the like.</p>
申请公布号 EP1020446(A1) 申请公布日期 2000.07.19
申请号 EP19990926895 申请日期 1999.07.02
申请人 TAIHO PHARMACEUTICAL CO., LTD. 发明人 NOGUCHI, KAZUHARU;WAKIDA, MOTOJI;SUZUKI, KENJI;YAMADA, YUJI;ASAO, TETSUJI
分类号 C07D221/14;C07D401/14;C07D471/04;C07D519/00;(IPC1-7):C07D221/14;C07D401/12;A61K31/535;A61K31/495;A61K31/47 主分类号 C07D221/14
代理机构 代理人
主权项
地址